A South African Medical Research Council (SAMRC) study has revealed that HIV remains one of the leading causes of death in ...

Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...

Researchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 ("INTEGRA") study at the 2025 ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Children exposed to antiretroviral (ARV) therapy in utero and not exposed to HIV showed no difference in language development at 5 years of age compared with unexposed children, based on new data from ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

The cuts to health aid have already interrupted essential services around the world, from antiretroviral therapy for HIV to ...

Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according ...

Results show similar levels of virus undetectability in patients on ibalizumab-containing regimens as in controls, despite greater baseline ...